Trinity Partners, a global life sciences consulting firm, today announced that it has welcomed its 21st annual class of recent graduates, onboarding 25 new hires. Hailing from top universities across the nation including Harvard, Duke, Vanderbilt, Dartmouth and Williams, these new additions to the company will join practice areas including Strategy Consulting, Advanced Analytics and Primary Market Research.
Trinity provides new hires with a comprehensive onboarding program to ensure they are set up for success, including hands-on sessions facilitated by over 60 percent of our tenured staff; a full client engagement simulation; and discussions focused on acclimating to the industry and general corporate work environment.
“Fostering employee growth and career development is one of Trinity’s top priorities,” said Michelle Adams, HR Director at Trinity Partners. “We are thrilled to welcome this class of new graduates in to a fast-paced work environment where they can learn as they grow, be exposed to new opportunities, and help biopharmaceutical companies tackle their most pressing business challenges.”
Trinity has more than 150 employees with offices in San Francisco, Princeton, New Jersey and New York City. Coming out of a busy first half of 2017, headlined by the release of a whitepaper analyzing the correlation between drug price and value, Trinity is well-positioned to continue to help clients identify opportunities and pain points. The company maintains an unwavering commitment to the development of its employees that drive its continued growth and broadening influence in the life sciences industry.
“No matter the industry or role, it is imperative to get some perspective. We are looking forward to seeing how Trinity’s new team members will be able to approach our unique business from an alternative angle, delivering meaningful and measurable results,” said Dave Fitzhenry, Partner at Trinity Partners.
About Trinity Partners: Trinity Partners is a trusted life sciences strategy consulting firm that takes a personalized approach to working with pharmaceutical, biotech, medical device, and diagnostic clients worldwide to create evidence-based solutions that drive business strategy and impact bottom lines. To learn more about our Partners, click here.